Results 251 to 260 of about 591,252 (334)
Clinical Genetics of Prolidase Deficiency: An Updated Review. [PDF]
Spodenkiewicz M+9 more
europepmc +1 more source
Clinical genetics in cancer prevention
Elsakov Pavel
doaj +1 more source
Microglia act as tumor suppressors during brain metastasis colonization but shift to a tumor‐promoting role after melanoma brain metastases form. NF‐κB/RelA signaling emerges as a key driver of this phenotypic shift. Targeting this pathway reprograms microglia into a pro‐inflammatory state, enhancing antitumor immunity and immune checkpoint inhibitor ...
Noam Savion‐Gaiger+2 more
wiley +1 more source
The impact of molecular genetics on the clinical management of pediatric sensorineural hearing loss [PDF]
Daniel Choo
openalex +1 more source
Genetics and clinical enzymology. [PDF]
openaire +2 more sources
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source
Growth in perceived clinical genetics competency among primary care providers participating in genomic population health screening. [PDF]
Hansen CA, Reiter AW, Wildin RS.
europepmc +1 more source
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani+14 more
wiley +1 more source